Antibiotic 1745A/X and methods for the production thereof
AssigneeHoffmann-La Roche Inc.
InventorsRichard Wightman Kierstead, Ronald Andrew Le Mahieu, David Pruess
Life of this patent
Estimating the term…
Abstract
A new antibiotic, designated as antibiotic 1745A/X, is produced by the fermentation of the known microorganism Streptomyces antibioticus, ATCC 11891, using the novel compound erythronolide A oxime as the substrate. This new antibiotic is useful as an antibacterial agent.
Claims1
A process for the preparation of antibiotic 1745A/X which comprises cultivating Streptomyces antibiotics ATCC 11891, under submerged aerobic conditions, in an aqueous nutrient medium containing assimilable sources of carbohydrates, nitrogen and inorganic salts, to which has been added erythronolide A oxime as the substrate, until substantial antibiotic activity is imparted to said medium by the production of antibiotic 1745A/X and the recovering the antibiotic 1745A/X so produced from said aqueous medium.
Dependencies are inferred from the claim text.